Jeff Davis of Acer Therapeutics
joined us for World Orphan Drug Congress USA 2015 to present about '
Developing Therapeutics for the Treatment of (Ultra) Orphan Diseases With Significant Unmet Medical Needs'.
Download the presentation now to learn about:
Normal Branched-chain Amino Acid Metabolism
NaPBA: Scientific Rationale for Lowering Leucine
NaPBA: Clinical Proof-of-Concept Study in MSUD
ACER-001: Pivotal Study Design/Development Plan
Get your copy here!
To find out more about how
Acer Therapeutics is developing therapeutics for treatment of (ultra) orphan diseases
, join us at
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.
Remember my details
Privacy statement »
Manage your email preferences »
You will be emailed the document as an attachment (1,852Kb in size)